Canopy Growth applies for landmark NYSE listing

By zaymalz malz

Canada’s biggest cannabis company Canopy Growth has applied to become the first cannabis company to be listed on the New York Stock Exchange (NYSE), marking a major milestone for the industry.

The company currently already trades on the Toronto Stock Exchange (TSE) under the symbol ‘WEED’ but expects to be listed under ‘CGC’ on the NYSE before the end of the month.

See also:

Canopy Growth is making the move in the aim gaining more traction south of the Canadian border, in the hopes that more institutional investors will see the company as a viable option and provide funding for a leading operator within one of the region’s fastest growing markets.

Canopy Growth to date does not have any operations within the US, and recreational marijuana still remains illegal within the country.

The firm is currently valued at more than CAD$6bn by market value, having see its stock more than triple in value over the course of the past 12 months.

Off the back of this strong performance, the company has most recently announced that it has agreed to acquire the outstanding shares of its research arm Canopy Health Innovations.


Featured Articles

JPMorgan Chase: Committed to supporting the next generation

JPMorgan has unveiled a host of new and expanded philanthropic activities totalling US$3.5 million to support the development of apprenticeship programmes

How efficient digital ecosystems became business critical

During this unprecedented era of rapid digital transformation, establishing a well-functioning ecosystem stands to benefit both employees and customers

Mastercard: Supporting clients at a time of rapid evolution

Mastercard has announced a significant expansion of its consulting business with the launch of new practices dedicated to both AI and economics

Why Ceridian has boldly rebranded to Dayforce

Human Capital

McKinsey’s eight lessons in leadership for aspiring CEOs

Leadership & Strategy

KPMG: The biggest challenges facing global CEOs in 2023

Leadership & Strategy